NFX.L
Nuformix PLC
Price:  
0.05 
GBP
Volume:  
21,623,752.00
United Kingdom | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NFX.L Relative Valuation

-829.5%
Upside

As of 2024-12-14, the Relative Valuation of Nuformix PLC (NFX.L) is (0.38) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 0.05 GBP, the upside of Nuformix PLC based on Relative Valuation is -829.5%.

The range of the Relative Valuation is (0.33) - (0.46) GBP.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 13.5x - 19.2x 16.4x
Forward P/E multiples 10.1x - 20.8x 15.4x
Fair Price (0.33) - (0.46) (0.38)
Upside -719.4% - -980.9% -829.5%
0.05 GBP
Stock Price
(0.38) GBP
Fair Price

NFX.L Relative Valuation - Historical P/E Data

Date P/E
2024-11-22 -1.95
2024-11-21 -1.97
2024-11-20 -2.08
2024-11-19 -2.14
2024-11-18 -2.14
2024-11-15 -2.08
2024-11-14 -2.03
2024-11-13 -2.08
2024-11-12 -2.06
2024-11-11 -2.12
2024-11-08 -2.08
2024-11-07 -2.18
2024-11-06 -2.18
2024-11-05 -2.22
2024-11-04 -2.26
2024-11-01 -2.39
2024-10-31 -2.59
2024-10-30 -2.59
2024-10-29 -2.49
2024-10-28 -2.59
2024-10-25 -2.59
2024-10-24 -2.59
2024-10-23 -2.59
2024-10-22 -2.49
2024-10-21 -2.59
2024-10-18 -2.59
2024-10-17 -2.59
2024-10-16 -2.59
2024-10-15 -2.49
2024-10-14 -2.59
2024-10-11 -2.49
2024-10-10 -2.32
2024-10-09 -2.59
2024-10-08 -2.59
2024-10-07 -2.39
2024-10-04 -2.28
2024-10-03 -2.39
2024-10-02 -2.28
2024-10-01 -2.28
2024-09-30 -2.43
2024-09-27 -2.35
2024-09-26 -2.53
2024-09-25 -2.41
2024-09-24 -2.64
2024-09-23 -2.63
2024-09-20 -2.59
2024-09-19 -6.44
2024-09-18 -6.44
2024-09-17 -6.12
2024-09-16 -6.02